FDA Investigator Seth A Abbott
Seth A Abbott has inspections in 1 countries as of 28 Dec 2023. Seth A Abbott has collaborated with a combined 1715 experts on various inspections, contributing to compliance and improvement across diverse sectors.
Investigator Details
Number of Inspected Sites:
60
Last Inspection Date:
28 Dec 2023
Investigator Role:
FDA Investigator
Redica ID:
Country:
United States of America
Co-Investigator(s):
Aaron L Dunbar,
Amos,
Amy L Mcintyre,
Anthony L Nicoli,
Aswin T Subketkaew,
Baask,
Bradley A Servais,
Bunce,
Carolyn A Warren,
Catherine M Vanderhoef,
Cheryl A Clausen,
Christina A Castineyra,
Christine M Erickson,
Como,
Constance Lrichard Math,
Courtney R Ingalsbe,
Courtney R Tiegs,
Dacia E Quick,
Darren D Holaday,
David B Wieneke,
David J Ward,
Debra D Devlieger,
Demetria L Lueneburg,
Dianna C Sonnenburg,
Douglas J Snyder,
Douglas W Atkins,
Duc Minh H Nguyen,
Edward A Fabiano,
Elizabeth P Mayer,
Emily E Markgraf,
Fallon J Ryan,
Fannie M Harrell,
Frank S Sedzielarz,
Garrett W Steiner,
Gina M Scholze,
Grant M Ruis,
Gregory W Smith,
Heather Akleimola Hulbert,
Heidi J Debeck,
Howard A Burmester,
Ivan E Reyes,
Jake T Lane,
Jane E Nelson,
Jeffery A Hangartner,
Jennifer R Mathern,
Jennifer S Ness,
Jeremy L Tri,
Jessica M Novak,
John T Quaife,
Jon C Polzine,
Julie Woodberry,
Karen M Labounty,
Karla J Youngberg,
Katherine A Clarke Girolamo,
Kellie L Westerbuhr,
Kenneth A Libertoski,
Kibily D Dembele,
Krista K Petersen,
Kristy E Zuroski,
Kyle J Mccracken,
Lauren E Merz,
Lauren E Sanger,
Linda V Weyer,
Mada A Tautges,
Madeline T Campbell,
Margaret M Lubbers Solberg,
Maria E Treadwell,
Marie A Fadden,
Melanie C Voges,
Melissa D Kalik,
Melissa I Michurski,
Michael E Cimaglio,
Mohammed H Adam,
Paola E Lathrop,
Rebecca L Caulfield,
Rebecca L Keller,
Richard W Koller,
Robert H Claflin,
Robert J Waldorf,
Rostislav Servetnyk,
Sana A Elassar,
Sandra A Hughes,
Sandra Sejdinovic,
Shaun M Olson,
State Agency,
Terrance L Scheiber,
Theresa C Klaman,
Tracy A Solseng,
Troy A Brenny,
Tyson J Eldridge Stedman,
Victoria L Palmer,
Wayne W Grundstrom,
Wendy L Trefethren Grang,
William E Keer,
Zachary P Wachlarowicz
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](https://redica.com/document-store/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more